CME: C-reactive protein and ESR: What can one tell you that the other can't?

Can you guess what condition Tiny Tim had?

This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.